K Webster - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

K Webster

Showing results (391-400 of 492) with videos related to

Pageof 50

Sort By:

Advances in Experimental Medicine and Biology|January 1, 1984

Effects of 3-deazaguanosine and 3-deazaguanine on the growth and maturation of the human promyelocytic leukemia cell line, HL-60D L Lucas, P K Chiang, H K Webster, et al.

British Journal of Cancer|November 9, 2013

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasiaP Nankivell, H Williams, C McConkey, et al.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998

Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type IP Y d'Avis, S C Robertson, A N Meyer, et al.

Hepatology (Baltimore, Md.)|November 1, 1982

H2-receptor antagonists and hepatic drug dispositionG W Mihaly, R A Smallwood, J D Anderson, et al.

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|May 26, 2010

Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?Patricia M Davidson, Jill Cockburn, Phillip J Newton, et al.

Journal of Medicinal Chemistry|November 12, 1993

Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNAK Vickery, A M Bonin, R R Fenton, et al.

British Journal of Cancer|July 1, 1992

Reversal of multidrug resistance by surfactantsD M Woodcock, M E Linsenmeyer, G Chojnowski, et al.

Annals of Plastic Surgery|July 14, 2023

Significant Reduction in Length of Stay in Deep Inferior Epigastric Perforator Flap Breast Reconstruction With Implementation of Multimodal ERAS ProtocolSthefano Araya, Theresa K Webster, Brian Egleston, et al.

Cancer Research|April 15, 1993

Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivoL Goya, D B Alexander, M K Webster, et al.

Annals of Plastic Surgery|February 20, 2026

A Novel Virtual Surgical Planning Technique Improves Outcomes in Endoscopic Suturectomy for Coronal CraniosynostosisTheresa K Webster, Albert Y Truong, Naikhoba Munabi, et al.

Pageof 50

Search research articles

Showing results (391-400 of 492) with videos related to

Sort By:

Pageof 50

Advances in Experimental Medicine and Biology|January 1, 1984

Effects of 3-deazaguanosine and 3-deazaguanine on the growth and maturation of the human promyelocytic leukemia cell line, HL-60D L Lucas, P K Chiang, H K Webster, et al.

British Journal of Cancer|November 9, 2013

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasiaP Nankivell, H Williams, C McConkey, et al.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 23, 1998

Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type IP Y d'Avis, S C Robertson, A N Meyer, et al.

Hepatology (Baltimore, Md.)|November 1, 1982

H2-receptor antagonists and hepatic drug dispositionG W Mihaly, R A Smallwood, J D Anderson, et al.

Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?Patricia M Davidson, Jill Cockburn, Phillip J Newton, et al.

Journal of Medicinal Chemistry|November 12, 1993

British Journal of Cancer|July 1, 1992

Reversal of multidrug resistance by surfactantsD M Woodcock, M E Linsenmeyer, G Chojnowski, et al.

Annals of Plastic Surgery|July 14, 2023

Cancer Research|April 15, 1993

Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivoL Goya, D B Alexander, M K Webster, et al.

Annals of Plastic Surgery|February 20, 2026

A Novel Virtual Surgical Planning Technique Improves Outcomes in Endoscopic Suturectomy for Coronal CraniosynostosisTheresa K Webster, Albert Y Truong, Naikhoba Munabi, et al.

Pageof 50